These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25601073)

  • 1. Antigenic potential of a highly conserved Neisseria meningitidis lipopolysaccharide inner core structure defined by chemical synthesis.
    Reinhardt A; Yang Y; Claus H; Pereira CL; Cox AD; Vogel U; Anish C; Seeberger PH
    Chem Biol; 2015 Jan; 22(1):38-49. PubMed ID: 25601073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia.
    Plested JS; Harris SL; Wright JC; Coull PA; Makepeace K; Gidney MA; Brisson JR; Richards JC; Granoff DM; Moxon ER
    J Infect Dis; 2003 Apr; 187(8):1223-34. PubMed ID: 12696001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits.
    Cox AD; Zou W; Gidney MA; Lacelle S; Plested JS; Makepeace K; Wright JC; Coull PA; Moxon ER; Richards JC
    Vaccine; 2005 Oct; 23(43):5045-54. PubMed ID: 16046037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B.
    Plested JS; Gidney MA; Coull PA; Griffiths HG; Herbert MA; Bird AG; Richards JC; Moxon ER
    J Immunol Methods; 2000 Apr; 237(1-2):73-84. PubMed ID: 10725453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.
    Plested JS; Ferry BL; Coull PA; Makepeace K; Lehmann AK; MacKinnon FG; Griffiths HG; Herbert MA; Richards JC; Moxon ER
    Infect Immun; 2001 May; 69(5):3203-13. PubMed ID: 11292742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures.
    Jäkel A; Plested JS; Hoe JC; Makepeace K; Gidney MA; Lacelle S; St Michael F; Cox AD; Richards JC; Moxon ER
    Vaccine; 2008 Dec; 26(51):6655-63. PubMed ID: 18835574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide heterogeneity and escape mechanisms of Neisseria meningitidis: possible consequences for vaccine development.
    Rune Andersen S; Kolberg J; Høiby EA; Namork E; Caugant DA; Oddvar Frøholm L; Jantzen E; Bjune G
    Microb Pathog; 1997 Sep; 23(3):139-55. PubMed ID: 9281472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera.
    Cox AD; St Michael F; Cairns CM; Lacelle S; Filion AL; Neelamegan D; Wenzel CQ; Horan H; Richards JC
    Glycoconj J; 2011 May; 28(3-4):165-82. PubMed ID: 21590368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive polyclonal antibodies to the inner core of lipopolysaccharide from Neisseria meningitidis.
    Andersen SR; Guthrie T; Guile GR; Kolberg J; Hou S; Hyland L; Wong SY
    Infect Immun; 2002 Mar; 70(3):1293-300. PubMed ID: 11854213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis.
    Plested JS; Makepeace K; Jennings MP; Gidney MA; Lacelle S; Brisson J; Cox AD; Martin A; Bird AG; Tang CM; Mackinnon FM; Richards JC; Moxon ER
    Infect Immun; 1999 Oct; 67(10):5417-26. PubMed ID: 10496924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity-oriented synthesis of inner core oligosaccharides of the lipopolysaccharide of pathogenic Gram-negative bacteria.
    Yang Y; Oishi S; Martin CE; Seeberger PH
    J Am Chem Soc; 2013 Apr; 135(16):6262-71. PubMed ID: 23521711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for selective cross-reactivity in a bactericidal antibody against inner core lipooligosaccharide from Neisseria meningitidis.
    Parker MJ; Gomery K; Richard G; MacKenzie CR; Cox AD; Richards JC; Evans SV
    Glycobiology; 2014 May; 24(5):442-9. PubMed ID: 24488440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates.
    Verheul AF; Boons GJ; Van der Marel GA; Van Boom JH; Jennings HJ; Snippe H; Verhoef J; Hoogerhout P; Poolman JT
    Infect Immun; 1991 Oct; 59(10):3566-73. PubMed ID: 1910006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to the epitope alpha-Gal-(1-4)-beta-Gal-(1- of Moraxella catarrhalis LPS react with a similar epitope in type IV pili of Neisseria meningitidis.
    Rahman M; Jonsson AB; Holme T
    Microb Pathog; 1998 May; 24(5):299-308. PubMed ID: 9600862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel inner-core oligosaccharide structure in Neisseria meningitidis lipopolysaccharide.
    Cox AD; Wright JC; Gidney MA; Lacelle S; Plested JS; Martin A; Moxon ER; Richards JC
    Eur J Biochem; 2003 Apr; 270(8):1759-66. PubMed ID: 12694188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: conjugates based on core oligosaccharides.
    St Michael F; Cairns CM; Filion AL; Biolchi A; Brunelli B; Giuliani M; Richards JC; Cox AD
    Glycoconj J; 2014 Jan; 31(1):25-39. PubMed ID: 24013955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and immunochemistry of meningococcal lipopolysaccharides.
    Jennings HJ; Beurret M; Gamian A; Michon F
    Antonie Van Leeuwenhoek; 1987; 53(6):519-22. PubMed ID: 3130788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis.
    Gidney MA; Plested JS; Lacelle S; Coull PA; Wright JC; Makepeace K; Brisson JR; Cox AD; Moxon ER; Richards JC
    Infect Immun; 2004 Jan; 72(1):559-69. PubMed ID: 14688137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antibacterial vaccination strategy based on a glycoconjugate containing the core lipopolysaccharide tetrasaccharide Hep2Kdo2.
    Kong L; Vijayakrishnan B; Kowarik M; Park J; Zakharova AN; Neiwert L; Faridmoayer A; Davis BG
    Nat Chem; 2016 Mar; 8(3):242-9. PubMed ID: 26892556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody against a carbohydrate epitope in lipopolysaccharide differentiates Chlamydophila psittaci from Chlamydophila pecorum, Chlamydophila pneumoniae, and Chlamydia trachomatis.
    Müller-Loennies S; Gronow S; Brade L; MacKenzie R; Kosma P; Brade H
    Glycobiology; 2006 Mar; 16(3):184-96. PubMed ID: 16282606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.